AAPL   323.34 (+0.00%)
MSFT   184.26 (-0.36%)
FB   229.84 (-1.24%)
GOOGL   1,435.81 (-0.45%)
AMZN   2,471.00 (-0.06%)
NVDA   349.55 (-0.98%)
BABA   215.40 (+0.50%)
MU   48.22 (+2.99%)
GE   7.23 (+2.55%)
AMD   52.61 (-1.76%)
ACB   14.37 (-1.10%)
F   6.14 (+3.90%)
GILD   74.15 (+1.21%)
DIS   121.92 (+2.67%)
BAC   26.05 (+4.87%)
AAPL   323.34 (+0.00%)
MSFT   184.26 (-0.36%)
FB   229.84 (-1.24%)
GOOGL   1,435.81 (-0.45%)
AMZN   2,471.00 (-0.06%)
NVDA   349.55 (-0.98%)
BABA   215.40 (+0.50%)
MU   48.22 (+2.99%)
GE   7.23 (+2.55%)
AMD   52.61 (-1.76%)
ACB   14.37 (-1.10%)
F   6.14 (+3.90%)
GILD   74.15 (+1.21%)
DIS   121.92 (+2.67%)
BAC   26.05 (+4.87%)
AAPL   323.34 (+0.00%)
MSFT   184.26 (-0.36%)
FB   229.84 (-1.24%)
GOOGL   1,435.81 (-0.45%)
AMZN   2,471.00 (-0.06%)
NVDA   349.55 (-0.98%)
BABA   215.40 (+0.50%)
MU   48.22 (+2.99%)
GE   7.23 (+2.55%)
AMD   52.61 (-1.76%)
ACB   14.37 (-1.10%)
F   6.14 (+3.90%)
GILD   74.15 (+1.21%)
DIS   121.92 (+2.67%)
BAC   26.05 (+4.87%)
AAPL   323.34 (+0.00%)
MSFT   184.26 (-0.36%)
FB   229.84 (-1.24%)
GOOGL   1,435.81 (-0.45%)
AMZN   2,471.00 (-0.06%)
NVDA   349.55 (-0.98%)
BABA   215.40 (+0.50%)
MU   48.22 (+2.99%)
GE   7.23 (+2.55%)
AMD   52.61 (-1.76%)
ACB   14.37 (-1.10%)
F   6.14 (+3.90%)
GILD   74.15 (+1.21%)
DIS   121.92 (+2.67%)
BAC   26.05 (+4.87%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Enzo BiochemAnpac Bio-Medical ScienceDermTechCelcuityPsychemedics
SymbolNYSE:ENZNASDAQ:ANPCNASDAQ:DMTKNASDAQ:CELCNASDAQ:PMD
Price Information
Current Price$3.05$7.60$13.40$10.16$5.93
52 Week RangeN/AN/ABuyBuyN/A
Beat the Market™ Rank
Overall Score0.70.52.11.01.1
Analysis Score0.00.03.51.50.0
Community Score2.52.72.82.53.0
Dividend Score0.00.00.00.01.7
Ownership Score1.00.04.01.01.0
Earnings & Valuation Score0.00.00.00.00.0
Analyst Ratings
Consensus RecommendationN/AN/ABuyBuyN/A
Consensus Price TargetN/AN/A$24.00$11.00N/A
% Upside from Price TargetN/AN/A79.10% upside8.27% upsideN/A
Trade Information
Market Cap$142.67 million$86.25 million$201.25 million$100.64 million$33.43 million
Beta0.77N/A0.851.010.84
Average Volume490,3832,69360,61019,99229,194
Sales & Book Value
Annual Revenue$81.17 million$1.56 million$3.36 millionN/A$37.68 million
Price / Sales1.7954.5659.46N/A0.87
CashflowN/AN/AN/AN/A$0.95 per share
Price / CashN/AN/AN/AN/A6.25
Book Value$1.81 per share($1.37) per share$1.01 per share$1.88 per share$3.05 per share
Price / Book1.69-5.5513.27N/A1.94
Profitability
Net Income$2.49 million$-14,520,000.00$-19,690,000.00$-7,360,000.00$1.54 million
EPSN/AN/AN/A($0.72)N/A
Trailing P/E Ratio76.270.000.00N/A42.36
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins1.92%N/AN/AN/A2.14%
Return on Equity (ROE)-31.31%N/A-69.34%-38.84%9.48%
Return on Assets (ROA)-22.22%N/A-56.78%-37.01%6.26%
Dividend
Annual PayoutN/AN/AN/AN/A$0.72
Dividend YieldN/AN/AN/AN/A12.14%
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/A2 Years
Debt
Debt-to-Equity Ratio0.32%N/AN/AN/A0.11%
Current Ratio3.06%0.33%13.13%20.16%2.19%
Quick Ratio2.74%0.33%13.11%20.16%2.19%
Ownership Information
Institutional Ownership Percentage60.64%0.02%39.14%22.22%47.58%
Insider Ownership Percentage9.40%N/A21.00%43.50%13.30%
Miscellaneous
Employees460N/A3626250
Shares Outstanding47.56 million11.20 million14.91 million10.26 million5.53 million
Next Earnings Date6/8/2020 (Estimated)N/AN/A8/13/2020 (Estimated)7/28/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.